Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

29.22 -0.45 (-1.52%)

Delayed Quote Updated: 1:58 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

61 62 Next >

Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - HIMS

July 11, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Kirby McInerney LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Class Action Filing and Encourages Investors to Contact the Firm

July 10, 2025

From Kirby McInerney LLP

Via Business Wire

Hims & Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

July 10, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Hims & Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

July 10, 2025

Via TheNewswire.com

Topics Lawsuit

Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Hims & Hers Health, Inc. (HIMS)

July 10, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Hims & Hers Health, Inc. (HIMS)

July 10, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

July 10, 2025

From Pomerantz LLP

Via GlobeNewswire

Multi-Billion Virtual Healthcare Industry Witnessing Substantial Growth with Rapid Expansion Expected

July 10, 2025

EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(NYSE:CVS),(NYSE:TDOC),(NASDAQ:TEM),(NYSE:HIMS) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS

July 09, 2025

From SkyMedia, LLC

Via GlobeNewswire

Multi-Billion Virtual Healthcare Industry Witnessing Substantial Growth with Rapid Expansion Expected

July 10, 2025

From FN Media Group LLC

Via GlobeNewswire

Hims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent Expires ↗

July 09, 2025

The telehealth company stated that its entry to Canada will come as generic semaglutide hits the market for the first time.

Via Stocktwits

Topics Intellectual Property

Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know

July 09, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced plans to expand into Canada with a weight-loss solution centered on generic...

Via StockStory

Topics Artificial Intelligence

What's Going On With Hims & Hers Health Stock Today? ↗

July 09, 2025

Hims & Hers announced plans to expand its weight loss program to Canada in 2026 in connection with the availability of generic semaglutide anywhere in the world.

Via Benzinga

Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - HIMS

July 09, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - HIMS

July 09, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion

July 09, 2025

From Hims & Hers

Via Business Wire

HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS

July 08, 2025

From Kahn Swick & Foti, LLC

Via GlobeNewswire

Oklo, NuScale, Hims Defy Trump Tariffs - And Power The Russell 2000 Toward New Highs ↗

July 08, 2025

Small caps outshine tariff fears as Russell 2000 nears all-time highs. Oklo, NuScale, Hims lead with gains of over 95% YTD despite trade turmoil.

Via Benzinga

Topics Government World Trade

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims & Hers Health, Inc. Lawsuit - HIMS

July 08, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims & Hers Health, Inc. Lawsuit - HIMS

July 08, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers, Sarepta, and Petco and Encourages Investors to Contact the Firm

July 07, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline

July 07, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits ↗

July 07, 2025

Hims & Hers faces stock pressure after Novo Nordisk ends Wegovy access, citing compounding violations and marketing concerns.

Via Benzinga

HIMS REMINDER: Kessler Topaz Meltzer & Check, LLP Urges HIMS Investors With Losses to Contact the Firm

July 07, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

HIMS REMINDER: Kessler Topaz Meltzer & Check, LLP Urges HIMS Investors With Losses to Contact the Firm

July 07, 2025

Via TheNewswire.com

Topics Lawsuit

Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for Investors - Contact Levi & Korsinsky

July 07, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for Investors - Contact Levi & Korsinsky

July 07, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Wegovy, Zepbound Prices Drop, But Most Patients Still Can't Afford Long-Term Use: 'Coverage Is Not The Same As Access,' Says Expert ↗

July 07, 2025

Via Benzinga

3 Cash-Heavy Stocks Worth Investigating

July 07, 2025

A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital.

Via StockStory

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

July 06, 2025

From Pomerantz LLP

Via GlobeNewswire

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

61 62 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.